Fortress Biotech FBIOP
NASDAQ FBIOP
$18.52 +0.25 (+1.40%)
As of: Aug 21, 2026 · 11:12 AM EDT

Fortress Biotech, Inc. (FBIOP) Finished Goods (2020 - 2025)

Fortress Biotech (FBIOP) posted quarterly Finished Goods of $10.0 million for Q1 2025, up 70.95% year-over-year from $5.9 million in Q1 2024, and down 11.91% quarter-over-quarter from $11.4 million in Q4 2024.

Fortress Biotech, Inc. (FBIOP) Finished Goods (2020 - 2025) Analysis & Trends

Fortress Biotech's Finished Goods history runs 6 years deep, the most recent figure standing at $10.0 million for Q1 2025.

  • In Q1 2025, Finished Goods rose 70.95% year-over-year to $10.0 million; the TTM figure through Mar 2025 stood at $10.0 million (up 70.95% YoY), while the FY2024 annual figure was $11.4 million, up 128.21% from the prior year.
  • Finished Goods for Q1 2025 stood at $10.0 million, down from $11.4 million in the prior quarter.
  • The five-year high for Finished Goods was $11.4 million in Q4 2024, with the low at $4.3 million in Q4 2021.
  • The 5-year median for Finished Goods is $7.1 million (2023), against an average of $7.3 million.
  • The sharpest annual moves came in 2021 and 2023: Finished Goods surged 205.56% in 2021, then slumped 35.56% in 2023.
  • Fortress Biotech's Finished Goods stood at $4.3 million in 2021, then soared by 80.4% to $7.7 million in 2022, then slumped by 35.56% to $5.0 million in 2023, then soared by 128.21% to $11.4 million in 2024, then slipped by 11.91% to $10.0 million in 2025.
  • Business Quant data shows FBIOP's Finished Goods at $10.0 million in Q1 2025, $11.4 million in Q4 2024, and $8.7 million in Q3 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 10.03 Mn
Dec 31, 2024 11.38 Mn
Sep 30, 2024 8.72 Mn
Jun 30, 2024 6.21 Mn
Mar 31, 2024 5.87 Mn
Dec 31, 2023 4.99 Mn
Sep 30, 2023 6.68 Mn
Jun 30, 2023 6.88 Mn
Mar 31, 2023 7.26 Mn
Dec 31, 2022 7.74 Mn
Sep 30, 2022 8.15 Mn
Jun 30, 2022 6.24 Mn
Mar 31, 2022 7.30 Mn
Dec 31, 2021 4.29 Mn
Sep 30, 2021 6.16 Mn
Jun 30, 2021 9.41 Mn
Dec 31, 2020 1.40 Mn